Sign in
Taking people in United KingdomNo phase

Body Clock Type and Blood Sugar Control in People With Diabetes

Studies how body clock type relates to blood sugar control in adults with diabetes.

Key facts

Who runs it
University of Leicester
Where
Leicester, United KingdomSee the site
Trial code
Registry title
Chronotype of Patients With Diabetes and Effect on Glycaemic Control
Status
Recruiting
People taking part
3,447 people, planned
Started
7 Dec 2016
Expected to end
31 Dec 2027
Type of study
Observational
Record updated
15 February 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 1 or long-standing type 2 diabetes to study how body clock type (chronotype) relates to blood sugar control.

Age
18 to 75 years
Sex
Men and women can both join.
Disease stage
Type 1 diabetes, or type 2 diabetes diagnosed more than 6 months ago.
Earlier treatment
On any glucose-lowering treatment, or lifestyle changes for type 2 diabetes.

Main reasons for not taking part

  • BMI above 45 kg/m²
  • Sleep disorder other than obstructive sleep apnoea
  • Weekly cannabis use
  • Terminal illness
  • Weekly use of wakefulness drugs, sedatives, melatonin or clonazepam

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Participant is willing and able to give informed consent for participation in the study
  • T1DM or established T2DM (>6months since diagnosis)
  • Male or Female
  • Aged 18-75 years inclusive
  • BMI less than or equal to 45kg/m² inclusive
  • No known sleep disorders except Obstructive Sleep Apnoea (OSA)
  • On any glucose-lowering therapy (T1DM or T2DM) or lifestyle modification for management of T2DM
  • Good command of the English language

Who cannot take part

  • Have a terminal illness
  • A known sleep disorder that is not OSA
  • Regular use of the following medicines i.e. Weekly use: (Wakefulness promoting agents Modafinil, Amphetamine derivatives, Methylphenidate; Sedatives including benzodiazepines, Z-drugs (zopiclone, zolpidem \& zaleplon); Melatonin, including Circadin and melatonin analogues; Clonazepam and other drugs for nocturnal movement disorders)
  • Anyone <18 years of age and >75 years of age
  • Participant is unwilling or unable to give informed consent
  • Anyone without a good command of the English language
  • BMI greater than 45 kg/m²
  • A regular cannabis user i.e. weekly use

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Where in United Kingdom

  • Leicester Diabetes Centre, Leicester General HospitalLeicester, United KingdomContact: Sahar Khodabakhsh, PhDTaking people

About the trial

What the trial wants to find out

The aim of this study is to explore the associations between chronotype and glycaemic control, cardiometabolic health and other lifestyle factors.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Chronotype of Patients With Diabetes and Effect on Glycaemic Control: The CODEC Study
Plain-language title
Body Clock Type and Blood Sugar Control in People With DiabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT02973412, who can take part
Publications
Record updated
15 February 2024